Pretomanid Completed Phase 3 Trials for Multidrug Resistant Tuberculosis / Extensively Drug Resistant Tuberculosis / Pulmonary Tuberculosis (TB) / XDR-TB / Tuberculosis (TB) / Pre-XDR-TB Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03086486Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis